Results 211 to 220 of about 1,287,782 (264)
TMEM184A promotes progression and drug resistance in colorectal cancer: a bioinformatics and clinical study. [PDF]
Bai X +7 more
europepmc +1 more source
Evolutionary antifragile therapy is a treatment strategy to suppress drug resistance by exploiting dose response convexity. [PDF]
West J +6 more
europepmc +1 more source
Stress-driven emergence of heritable non-genetic drug resistance
Jarosz D +12 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drug Discovery Today: Technologies, 2014
Drug resistance is a fundamental problem in the treatment of cancer since cancer that becomes resistant to the available drugs may leave the patient with no therapeutic alternatives. In this chapter, we consider the dynamics of drug resistance in blood cancer and the related issue of the dynamics of cancer stem cells. After describing the main types of
Gemma, Texidó, Jürgen, Moll
openaire +4 more sources
Drug resistance is a fundamental problem in the treatment of cancer since cancer that becomes resistant to the available drugs may leave the patient with no therapeutic alternatives. In this chapter, we consider the dynamics of drug resistance in blood cancer and the related issue of the dynamics of cancer stem cells. After describing the main types of
Gemma, Texidó, Jürgen, Moll
openaire +4 more sources
British Medical Bulletin, 1991
Chemotherapy cures a minority of adult tumours (e.g. Hodgkin's and non-Hodgkin's lymphoma, acute leukaemia, teratoma) and the majority of childhood tumours. Prolongation of survival by chemotherapy has been shown for small cell lung cancer, ovarian cancer and breast carcinoma (when used as an adjuvant).
D, Hochhauser, A L, Harris
openaire +2 more sources
Chemotherapy cures a minority of adult tumours (e.g. Hodgkin's and non-Hodgkin's lymphoma, acute leukaemia, teratoma) and the majority of childhood tumours. Prolongation of survival by chemotherapy has been shown for small cell lung cancer, ovarian cancer and breast carcinoma (when used as an adjuvant).
D, Hochhauser, A L, Harris
openaire +2 more sources

